For decades, scientists around the world have dreamed of medical interventions to repair or replace defective genes in a targeted way. Today, that vision is becoming reality for an ever-growing number of debilitating and deadly diseases thanks to breakthroughs in gene therapy technology. But if millions of Americans are to benefit from these advances, our health care system needs to adapt.
To read this piece, please visit The Hill.